Call for an instant quote 0345 90 80 161
Open Mon to Fri 09:00 - 17:30 | Sat 09:00 - 16:00 (GMT)
30 November 2015 08:09
Breast cancer kills around 11,500 people in the UK each year
A combination of immunotherapy and chemotherapy could provide the key to treating breast cancer patients who have become resistant to existing drugs, new research suggests.
An international team of scientists tested the dual therapy on mice and say their results were "striking".
Experts at the Breast Cancer Care charity say they hope the study will be followed by further clinical trials and pave the way for the development of better treatments.
Researchers say the fact that the mice stayed free of cancer even after being given fresh tumours suggests the combined treatment provided them with ongoing immune protection.
Breast cancer has not previously been known to respond well to immunotherapy but pairing it with targeted chemotherapy produced some startling results, the research team says.
The therapy prevented tumours in the mice from being able to protect themselves from the immune system, enabling them to be attacked by cancer-fighting immune cells.
The type of cancer used by the team is one known as Her2 positive. It affects up to a fifth of all women with breast cancer and in the majority of cases results in patients becoming resistant to the drug Herceptin and other treatments.
But research leader Dr Philipp Muller, of Switzerland's University of Basel, says the technique made the tumours highly vulnerable to antibody-based immunotherapy.
It saw the mice given a chemotherapy drug and a variety of antibodies, including some which stopped the cancers shielding themselves from the animals' immune systems.
Breast cancer should not mean an end to life's luxuries, and holidaymakers can cover themselves with the help of cancer travel insurance policies.
Breast Cancer Care's Jackie Harris describes the research as interesting and a welcome forward step.
The clinical nurse specialist says the results of the early study open up the possibility of breast cancer patients who have become resistant to current drugs being treated in an alternative way in the future.
She adds that while Her2 positive breast cancer is hard to treat, research will provide the key to more effective treatments being developed.
The new study is published in the Science Translational Medicine journal.
22 September 2018
The NHS should switch to electric vehicles across its organisations, health officials have advised.
[more...]
21 September 2018
UK holidaymakers could be missing out on more than 60 direct flight routes thanks to Air Passenger Duty (APD), a report suggests.
20 September 2018
Living in areas with high levels of air pollution could be linked to an increased risk of dementia, new research suggests.
19 September 2018
Multiple sclerosis (MS) patients are shelling out tens of thousands of pounds for care - and many are unable to cover the costs, a leading charity has warned.
18 September 2018
As much as £6 of every £10 spent on domestic flights in the UK goes on Air Passenger Duty (APD), new research suggests.
15 September 2018
UK driving licences might become invalid in certain European countries if the UK crashes out of the EU with no deal, the Government has warned.
14 September 2018
Online crowdfunding for cancer treatments is indirectly advancing the rise of alternative "quack" therapies, experts have warned.
13 September 2018
A "wee-stick" like those used in pregnancy testing could be employed to prevent thousands of deaths from ovarian cancer.
11 September 2018
As many as 1.3 million passengers endured severe flight delays in the last year, a new study reveals.
08 September 2018
British Airways customers are cancelling their credit cards after the carrier was hit by a 15-day data breach that compromised the details of around 380,000 people.
06 September 2018
Plastic trays at security desks harbour the highest numbers of viruses at airports, new research has discovered.
05 September 2018
Adults are being urged to take advantage of a new online tool to find out if they are at risk of having a heart attack or stroke.